Cell BiologybioRxivPreprint
LGR5 targeting molecules as therapeutic agents for multiple cancer types
H.-C. Chen, N. Mueller, K. Stott…·M. de la Roche
This study develops LGR5-targeting antibodies and therapeutics that effectively kill CRC, HCC, and pre-B ALL cancer cells while sparing normal tissues.
DOI 10.1101/2022.09.01.506182